“This is a big country, and we still haven’t been able to settle the testing issue. It doesn’t make any sense,” Michael Dacey told The Wall Street Journal.
Healthcare providers in the US are again limiting who is able to get a coronavirus test due to shortages of supplies needed to process the test, The Wall Street Journal reported.
These shortages come as the fall season the US is beginning.
Flu tests also require the same supplies that the COVID-19 test needs.
Visit Business Insider’s homepage for more stories.
A shortage of a chemical used to process the COVID-19 test has caused healthcare systems across the US to limit who is able to get a test — right before the start of the flu season — The Wall Street Journal reported.
Some hospitals and facilities have gone back to limiting tests to the most vulnerable patients as supplies dwindle.
Mark Steadham, president and chief executive of Morris Hospital and Healthcare Centers, told The Journal that his hospitals are only getting about a third of their usual Abbott testing kits forcing them to scale back their testing.
“We felt like we were just starting to get ahead of the virus,” Steadham told The Journal about the testing decline.
Michael Dacey, president of Riverside Health System in Newport News, Virginia, also told The Journal that his hospital cut testing by 20% due to limited supplies. Those who are suspected of having COVID-19 but aren’t ill enough to be admitted to the hospital don’t get a test.
“This is a big country, and we still haven’t been able to settle the testing issue. It doesn’t make any sense,” Dacey told The Journal.
Public health experts sounded alarms last month when testing declined by 13%. That came after labs were so…
Read full article